Robert Califf

FDA Commissioner Califf's Pharmaceutical Industry Revolving Door Scrutinized

| Importance: 8/10

FDA Commissioner Robert Califf faces ongoing criticism for his extensive pharmaceutical industry ties. Having received over $8 million from drug companies and worked as a consultant for major pharmaceutical firms, Califf pledged to extend post-employment restrictions from 2 to 4 years to mitigate …

Robert Califf FDA Verily Life Sciences Joe Manchin Bernie Sanders regulatory-capture pharmaceutical-industry fda corporate-influence government-ethics
Read more →

FDA Commissioner Confirmed Amid Pharmaceutical Industry Ties Controversy

| Importance: 8/10

Dr. Robert Califf confirmed as FDA Commissioner by a narrow Senate vote of 50-46, highlighting ongoing concerns about pharmaceutical industry regulatory capture. Historical evidence suggests a systemic ‘revolving door’ between FDA and pharmaceutical companies, with approximately 27% of …

Robert Califf Senate FDA Leadership Pharmaceutical Industry Executives regulatory-capture revolving-door pharmaceutical-industry conflict-of-interest senate-confirmation
Read more →